GPT and depressive disorder: The investigators did not notice any deaths, but the treatment was discontinued in one patient in the ELX/TEZ/IVA group because of elevated SGOT and SGPT levels and in two patients in the active control group due to anxiety, depression and pulmonary exacerbation [14].